UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 2 von 5
Datensatz exportieren als...
BibTeX
Anesthesia for Dental and Oral Maxillofacial Surgery
Wade, Spencer D
Sawicki, Caroline M
Smiley, Megann K
Cuddy, Michael A
Vukas, Steven
Schwartz, Paul J
1st ed, 2024
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Wade, Spencer D
Sawicki, Caroline M
Smiley, Megann K
Cuddy, Michael A
Vukas, Steven
Schwartz, Paul J
Titel
Anesthesia for Dental and Oral Maxillofacial Surgery
Auflage
1st ed
Ort / Verlag
Newark : John Wiley & Sons, Incorporated,
Erscheinungsjahr
2024
Beschreibungen/Notizen
Cover -- Title Page -- Copyright Page -- Dedication Page -- Contents -- Editorial Board -- Acknowledgments and Contributors -- Preface -- Oral/Written Boards -- Dentist Contributions to Anesthesiology -- Glossary of Abbreviations -- Section 1 Statistics I Physics I Equipment -- 1.1 Statistics -- Normal Distribution (Figure 1.1) -- Variables -- Basic Statistical Tests -- Research Methodologies (Figure 1.2) -- 1.2 Anesthetic Monitoring Standards -- Standard I (Figure 1.3) -- Standard II (Figure 1.4) -- 1.3 Pulse Oximetry -- Function -- Clinical Considerations -- 1.4 Electrocardiography -- Function -- Clinical Considerations -- 1.5 Blood Pressure Monitors -- Noninvasive Blood Pressure Cuff -- Arterial Line -- 1.6 Temperature Monitoring -- Function -- Clinical Considerations -- 1.7 Ventilation Monitoring -- Pretracheal/Precordial Stethoscope -- Capnography -- 1.8 Capnograms (Figures 1.9 & -- 1.10) -- 1.9 Fluid and Gas Physics -- Laminar Flow -- 1.10 Medical Gas -- Characteristics (Figure 1.13) -- Nitrous Oxide -- Gas Supply Colors (Figure 1.14) -- 1.11 Mapleson Circuit -- Characteristics (Figure 1.15) -- 1.12 Circle System -- Humidifiers -- Carbon Dioxide Absorbent -- 1.13 Anesthesia Machine Safety Features -- 1.14 Vaporizer -- Vapor Pressure (Figures 1.18 & -- 1.19) -- Safety Features -- Desflurane Vaporizer -- 1.15 Ventilator -- Common Ventilator Modes -- Components and Safety Features -- 1.16 Infusion Pump -- Components and Safety Features -- References -- Section 2 Anatomy I Physiology -- 2.1 Body Fluids -- Fluid Compartments -- 2.2 Intravenous Fluids -- Fluid Composition -- Crystalloids -- Colloids -- 2.3 Head and Neck Blood Supply (Figures 2.2 & -- 2.3) -- 2.4 Sensory Nerves (Figure 2.4) -- 2.5 Cranial Nerves -- CN I (Olfactory) -- CN II (Optic) -- CN III (Oculomotor) -- CN IV (Trochlear) -- CN V (Trigeminal).
Ophthalmic Branch (V1) -- Maxillary Branch (V2) -- Mandibular Branch (V3) -- CN VI (Abducens) -- CN VII (Facial) -- CN VIII (Vestibulocochlear) -- CN IX (Glossopharyngeal) -- CN X (Vagus) -- CN XI (Spinal Accessory) -- CN XII (Hypoglossal) -- 2.6 Neuromuscular Junction -- Anatomy -- Muscle Contraction -- 2.7 Parasympathetic Nervous System -- Anatomy -- Physiology (Figures 2.10 & -- 2.11) -- Receptors -- 2.8 Sympathetic Nervous System -- Anatomy -- Physiology (Figures 2.12 & -- 2.13) -- Receptors -- 2.9 Brain -- Anatomy -- Function -- Cerebral Blood Flow (CBF) -- Cerebral Blood Flow Regulation (Figure 2.15) -- Innervation -- Cerebrospinal Fluid -- Anterior Pituitary Hormones -- Posterior Pituitary Hormones -- 2.10 Spinal Cord -- Anatomy -- Function -- Blood Flow -- Innervation -- Endocrine/Exocrine -- 2.11 Cardiac -- Anatomy -- Function -- Cardiac Blood Flow (Figure 2.17) -- Innervation -- Cardiac Output (Figure 2.18) -- Flow-Volume Loop (Figure 2.20) -- Conduction -- Cardiac Action Potentials (Figures 2.21 & -- 2.22) -- Endocrine/Exocrine -- 2.12 Pulmonary -- Anatomy -- Function -- Pulmonary Blood Flow -- Innervation -- Ventilation -- Shunts and Dead Space (Figure 2.23) -- Oxygen-Hemoglobin Dissociation Curve (Figure 2.24) -- Blood Oxygen Calculations (Figure 2.25) -- Acid-Base Balance (Figure 2.26) -- Endocrine/Exocrine -- 2.13 Renal -- Anatomy -- Function -- Renal Blood Flow -- Innervation -- Renal Volume Management (Figures 2.27 & -- 2.28) -- Urine Concentration (Figure 2.29) -- Acid-Base Balance -- Endocrine/Exocrine -- 2.14 Hepatic and Biliary -- Anatomy -- Function -- Hepatic Blood Flow (Figure 2.30) -- Innervation [6] -- Endocrine/Exocrine -- 2.15 Gastrointestinal -- Anatomy -- Function -- Blood Flow -- Innervation -- Endocrine -- Exocrine -- 2.16 Pancreas -- Anatomy -- Function -- Blood Supply -- Innervation.
Endocrine/Exocrine (Figure 2.31) -- 2.17 Thyroid -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- 2.18 Parathyroid -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine (Figure 2.33) -- 2.19 Adrenal Gland -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- 2.20 Vascular -- Anatomy (Figure 2.35) -- Function -- Innervation -- Blood Supply -- Endocrine/Exocrine -- Blood Pressure Regulation -- 2.21 Hematology -- Anatomy (Figure 2.36) -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- Platelet Plug and Coagulation Cascade -- Endogenous Anticoagulants -- References -- Section 3 Preoperative Assessment -- 3.1 Psychology -- Dental Fear and Anxiety -- Nonpharmacologic Behavior Management [3] -- 3.2 Sedation Levels -- Minimal Sedation -- Moderate Sedation -- Deep Sedation -- General Anesthesia -- 3.3 ASA Physical Status Classification -- ASA I -- ASA III -- ASA V -- ASA II -- ASA IV -- ASA VI -- NPO -- NPO Guidelines [4] -- Aspiration -- 3.4 Preoperative Cardiac Testing -- Procedure -- Metabolic Equivalent of Tasks (METs) -- 3.5 Preoperative Pulmonary Testing -- Chest Radiography -- Pulmonary Function Testing -- Flow-Volume Loops (Figure 3.10) -- Diffusing Lung Capacity -- 3.6 Preoperative Labs -- Blood Glucose -- Hemoglobin A1c (HbA1c) -- Basic Metabolic Panel (BMP) (Figure 3.11) -- Arterial Blood Gas -- Complete Blood Count (Figure 3.12) -- Coagulation Study (Figure 3.13) -- Liver Function Tests -- Thyroid Testing -- Pregnancy Testing -- Type and Screen -- Type and Cross -- 3.7 Airway Evaluation -- Previous Airway/Intubations History -- Presence/Suspicion of Obstructive Sleep Apnea (OSA) (Figure 3.15) -- Clinical Airway Evaluation -- Nasal Intubation Specifics -- Predictors of Difficult Airway -- References -- Section 4 Outpatient Medications.
4.1 Antibiotic Prophylaxis (Figures 4.1-4.6) -- Infective Endocarditis -- 4.2 Smoking -- Effects of Smoking -- Smoking Cessation [6] -- 4.3 Substance Use Disorder Treatment -- Varenicline -- Acamprosate -- Disulfiram -- Naltrexone -- Methadone -- Buprenorphine [18] -- 4.4 Antiplatelets -- Cyclooxygenase (COX) Inhibitors (NSAIDs) -- Thienopyridines -- 4.5 Anticoagulants (Figure 4.9) -- Direct Thrombin Inhibitors -- Heparin -- Warfarin -- Direct Factor Xa Inhibitors -- 4.6 Antihypertensives -- Angiotensin-Converting Enzyme Inhibitors -- Angiotensin Receptor Blockers -- Calcium Channel Blockers (Dihydropyridines) -- Nitrates -- 4.7 Diuretics -- Thiazides -- Loop Diuretics -- Potassium Sparing Diuretics -- 4.8 Antidysrhythmics -- -Blockers (Figures 4.12 & -- 4.13) -- Digoxin -- Calcium Channel Blockers (Non-dihydropyridines) -- 4.9 Pulmonary -- β2 Receptor Agonists -- Corticosteroids -- Anticholinergics -- Methylxanthines -- Histamine-1 Receptor Antagonists -- Leukotriene Receptor Antagonists -- 5-Lipoxygenase Inhibitors -- 4.10 Non-Insulin Hypoglycemics -- Biguanides -- Sulfonylureas -- Meglitinides -- Thiazolidinediones (TZDs) -- Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) -- α-Glucosidase Inhibitors -- Dipeptidyl Peptidase-4 Inhibitors (DPP-4) -- Glucagon-Like Peptide 1 Receptor Agonists (GLP-1) -- 4.11 Insulin -- Rapid-Acting Insulin -- Regular-Acting Insulin -- Intermediate-Acting Insulin -- Long-Acting Insulin -- Insulin Pumps -- 4.12 Antidepressants -- Tricyclics (TCAs) -- Monoamine Oxidase Inhibitors (MAOIs) -- Atypical Antidepressants -- Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) -- Selective Serotonin Reuptake Inhibitors (SSRIs) -- 4.13 Psychiatric -- Antipsychotics -- α2 Adrenergic Agonists -- Lithium -- Amphetamines -- Sleep Aids -- 4.14 Neurologic -- Antiepileptics [51] -- Dopaminergics -- Cholinesterase Inhibitors.
4.15 Gastrointestinal -- H2 Receptor Antagonists -- Proton Pump Inhibitors (PPI) -- Antacids -- 4.16 Glucocorticosteroids -- Glucocorticosteroids -- Steroid Equivalency Chart -- 4.17 Other Medications -- Statins -- Thyroid -- Antiretrovirals -- Ophthalmic -- Herbal Medications -- α1 Adrenergic Antagonists -- References -- Section 5 The Perioperative Pharmacology -- 5.1 Inhalational Pharmacokinetics and Pharmacodynamics -- Mechanism of Action -- Minimum Alveolar Concentration (MAC) -- Minimum Alveolar Concentration (Definitions) -- Factors Affecting MAC (Figure 5.2) -- Factors Affecting Inhalational Onset -- Distribution -- Metabolism -- Elimination -- 5.2 Inhalational Agents -- Nitrous Oxide -- Isoflurane -- Desflurane -- Sevoflurane -- 5.3 Intravenous Pharmacokinetics and Pharmacodynamics -- Factors Affecting Onset -- Distribution -- Hepatic Metabolism -- Hepatic Clearance -- Renal Clearance (Figure 5.11) -- 5.4 Intravenous Induction Agents -- Propofol -- Ketamine -- Etomidate -- Methohexital -- 5.5 Benzodiazepines -- Diazepam -- Midazolam -- Remimazolam -- Flumazenil -- 5.6 Opioids -- Opioid Receptor -- Equianalgesic -- Morphine -- Fentanyl -- Hydromorphone -- Remifentanil -- Naloxone -- Other Opioids -- 5.7 Non-opioid IV Analgesics -- Ketamine -- Acetaminophen -- Ketorolac -- Dexmedetomidine -- 5.8 Neuromuscular Monitoring -- Clinical Evaluation -- Peripheral Nerve Stimulator -- Train of Four -- Nerves -- Factors Affecting Neuromuscular Blockade (Figure 5.15) -- Quantitative Neuromuscular Monitoring [60] -- 5.9 Neuromuscular Blocking Agents -- Succinylcholine -- Rocuronium -- Vecuronium -- Cisatracurium -- 5.10 Neuromuscular Reversal Agents -- Sugammadex -- Neostigmine -- Atropine -- Glycopyrrolate -- 5.11 Hypertensive Agents -- Phenylephrine -- Norepinephrine -- Epinephrine -- Ephedrine -- Vasopressin -- 5.12 Antihypertensive Agents.
Clevidipine.
Description based on publisher supplied metadata and other sources.
Sprache
–
Identifikatoren
ISBN: 1-394-16492-0, 1-394-16490-4
Titel-ID: 9925175956106463
Format
1 online resource (355 pages)